N. Erdoğdu, "Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma," Annals of Medical Research , vol.29, no.3, pp.198-202, 2022
Erdoğdu, N. 2022. Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma. Annals of Medical Research , vol.29, no.3 , 198-202.
Erdoğdu, N., (2022). Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma. Annals of Medical Research , vol.29, no.3, 198-202.
Erdoğdu, NAZLI. "Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma," Annals of Medical Research , vol.29, no.3, 198-202, 2022
Erdoğdu, NAZLI. "Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma." Annals of Medical Research , vol.29, no.3, pp.198-202, 2022
Erdoğdu, N. (2022) . "Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma." Annals of Medical Research , vol.29, no.3, pp.198-202.
@article{article, author={NAZLI ERDOĞDU}, title={Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma}, journal={Annals of Medical Research}, year=2022, pages={198-202} }